Skip to search formSkip to main contentSkip to account menu

STK33 gene

Known as: STK33, Serine/Threonine Kinase 33 Gene, SERINE/THREONINE PROTEIN KINASE 33 
This gene is involved in protein phosphorylation.
National Institutes of Health

Related topics

Related topics

5 relations
PhosphorylationSTK39 geneSerine/Threonine Kinase 33Serine/Threonine Phosphorylation

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
STK33 Promotes the Growth and Progression of Human Pancreatic Neuroendocrine Tumour via Activation of the PI3K/AKT/mTOR Pathway
Background: Serine/threonine kinase 33 (STK33) has been reported to play an important role in cancer cell proliferation. We… 
2017
2017
Abstract LB-142: Identification of STK33 as a cancer stemness kinase and regulator of Nanog function
In recent years evidence has accumulated in support of the cancer stem cell (CSC) model in cancer chemotherapy resistance… 
2016
2016
Progress of STK 33 in Cancer Biology
In recent years, serine/threonine kinase 33 (STK33) has attracted considerable attention in tumor biology. STK33 displays a… 
2015
2015
Exploring genetic markers of adult obesity risk in black adolescent South Africans—the Birth to Twenty Cohort
To date more than 90 loci that show an association with body mass index (BMI) and other obesity-related traits, have been… 
2014
2014
Screen for Inhibitors of STK33 Kinase Activity
2014
2014
Figure 2, STK33 Inhibitors
2014
2014
Table 19, Comparison of the probes to reported STK33 inhibitors
2011
2011
STK33 kinase is not essential in KRAS-dependent cells--letter.
Babij and colleagues report that STK33 is dispensable for KRASmut-dependent cancer cells ([1][1]), a finding in contrast to… 
2011
2011
STK33 strikes out
Amgen has dropped its STK33 program after company scientists were unable to reproduce academic findings that serine/threonine… 
2011
2011
Therapeutics , Targets , and Chemical Biology STK 33 Kinase Activity Is Nonessential in KRAS-Dependent Cancer Cells
Despite the prevalence of KRAS mutations in human cancers, there remain no targeted therapies for treatment. The serine–threonine… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)